Product Information
RALOXIFENE HCL 60 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2399 per EA under NDC 00093729001. Its NADAC has been published 628 times since Jun 18, 2014.
Strength
60 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093729001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RALOXIFENE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078193On Market Since
3/28/2014
Pharmacological Classes
Price Statistics
The NADAC for RALOXIFENE HCL 60 MG TABLET has been published 628 times since Jun 18, 2014, and over the history we have for it it has declined 95.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2399 per EA |
|---|---|
| All-time high | $5.1547 (Jul 16, 2014) |
| All-time low | $0.2054 (Nov 20, 2024) |
| 52-week high | $0.2670 |
| 52-week low | $0.2397 |
| Median price | $0.4998 |
| Average price | $1.0816 |
| Largest weekly change | +31.5% (Jan 22, 2020) |
| Weeks tracked | 628 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RALOXIFENE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for RALOXIFENE HCL 60 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2399 per EA (NDC 00093729001), effective Jun 24, 2026.
How has the price of RALOXIFENE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for RALOXIFENE HCL 60 MG TABLET has declined 95.3%. It has been tracked across 628 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for RALOXIFENE HCL 60 MG TABLET?
Since Jun 18, 2014, the NADAC for RALOXIFENE HCL 60 MG TABLET has ranged from a low of $0.2054 (Nov 20, 2024) to a high of $5.1547 (Jul 16, 2014), with a median of $0.4998 per EA.
Are there cheaper alternatives to RALOXIFENE HCL 60 MG TABLET?
6 NADAC-published products share the same active ingredient, strength, and dosage form as RALOXIFENE HCL 60 MG TABLET, but none are currently priced below it.
Who manufactures RALOXIFENE HCL 60 MG TABLET?
RALOXIFENE HCL 60 MG TABLET (NDC 00093729001) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification